İ. DOĞAN Et Al. , "Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib," European Lung Cancer Virtual Congress 2021 (ELCC 2021 Virtual) , vol.16, SANAL KONGRE, Turkey, 2021
DOĞAN, İ. Et Al. 2021. Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib. European Lung Cancer Virtual Congress 2021 (ELCC 2021 Virtual) , (SANAL KONGRE, Turkey).
DOĞAN, İ., KHANMAMMADOV, N., PAKSOY, N., FERHATOĞLU, F., AYDIN, E., VATANSEVER, S., ... SAİP, P. M.(2021). Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib . European Lung Cancer Virtual Congress 2021 (ELCC 2021 Virtual), SANAL KONGRE, Turkey
DOĞAN, İZZET Et Al. "Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib," European Lung Cancer Virtual Congress 2021 (ELCC 2021 Virtual), SANAL KONGRE, Turkey, 2021
DOĞAN, İZZET Et Al. "Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib." European Lung Cancer Virtual Congress 2021 (ELCC 2021 Virtual) , SANAL KONGRE, Turkey, 2021
DOĞAN, İ. Et Al. (2021) . "Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib." European Lung Cancer Virtual Congress 2021 (ELCC 2021 Virtual) , SANAL KONGRE, Turkey.
@conferencepaper{conferencepaper, author={İZZET DOĞAN Et Al. }, title={Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib}, congress name={European Lung Cancer Virtual Congress 2021 (ELCC 2021 Virtual)}, city={SANAL KONGRE}, country={Turkey}, year={2021}}